Colorado Heart & Vascular performs the first novel procedure in Colorado for peripheral arterial disease
DENVER – Nov. 11, 2014 – Rose Medical Center is the first hospital in Colorado to perform a new and innovative procedure for patients with peripheral arterial disease (PAD). Utilizing the LUTONIX ® 035 Drug Coated Balloon PTA Catheter, surgeons are able to perform a balloon angioplasty in patients with PAD using a special drug-coated balloon (DCB) that delivers a small amount of medication to the inside walls of the diseased portion of the artery.
FOR IMMEDIATE RELEASE
DENVER – October 1, 2014
Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances. The LARIAT™ procedure utilizes the LARIAT™ Suture Delivery Device and non-invasive techniques to access the heart and close off a region of the heart known to cause blood clots that can lead to stroke as a consequence of atrial fibrillation.
“This is the first therapy we have had to offer patients who are at high risk of stroke but unable to take anticoagulants,” says Dr. Tom Svinarich, Rose Medical Center interventional electrophysiologist. “We can now prevent strokes in patients who are otherwise at high risk of bleeding on oral anticoagulants.”
We are committed to superior patient care. Our primary focus is and always has been you, the patient. Please explore our web site to find links to our locations, forms for you to download, information about your upcoming tests and procedures, and contact information for our scheduling and billing departments.
Colorado Heart and Vascular Echocardiography Laboratory Receives Echocardiography Accreditation by the IAC
Cardiovascular diseases are the No. 1 cause of death in the United States. On average, one American dies every 39 seconds of cardiovascular disease – disorders of the heart and blood vessels. The American Heart Association estimates that the direct and indirect cost for cardiovascular disease in the U.S. for 2010 was $503.2 billion.
"Mehta would like to see full disclosure of what’s in energy drinks. He’d also like to see regulation of how much caffeine they can contain. He urges parents to pay close attention to what their children are drinking."
WARFARIN Study at Colorado Heart & Vascular to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
To improve patient safety and reduce healthcare costs, Denver takes major role in first personalized medicine study authorized by Centers for Medicare & Medicaid Services